FULVEKAST
Fulvestrant Injection 250mg/5ml
FULVEKAST
Composition – Fulvestrant 250mg/5ml
Pre-filled syringes for intramuscular use only
Classification: Anticancer, Antineoplastic
Fulvekast (fulvestrant) is widely accepted and prescribed to treat HER2-positive and HER-2 negative advanced or metastatic breast cancer in postmenopausal women.
It is also used to treat tumors resistant to endocrine therapy or worsened cancers after hormonal therapy.
How does Fulvekast work?
- • Selective Estrogen Receptor Antagonist.
- • It inhibits estrogen hormone, which causes cancer cells to grow.
- • Stops cancer cell growth.
- • Shrink the tumor.
Why choose a Fulvekast prefilled injection?
- • Better convenience – Pre-filled syringes are quick and ready to use.
- • Precise dose- Accurate and safe dosages.
- • Wider Global access – Readily available at varied hospital care settings, public healthcare clinics.
Fulvekast Prefilled Syringe: Advanced Care for Treatment-Resistant Breast Cancer
As a preferred second-line or subsequent-line option, fulvestrant leads to longer progression–free survival in advanced breast cancer in postmenopausal women.
Directly down-regulate the receptor, offering complete blockade.
Has better tolerance and a favorable safety profile.
Contra-indications:
Avoid its use in –
• Pregnant women
• Lactating mother
• Hypersentivity
Careful use is required in Patients with–
• blood disorders
• Hepatic impairment
• Children
• Elderly patients who are at risk of osteoporosis.
• Vitamin D or Calcium deficiency
Adverse drug effects
- • Risk of bleeding, Sore throat, mouth sores, upset stomach, nausea, loss of appetite, headache, and tiredness.
- • Flushing or redness of the skin at the site of injection
Serious side effects
- • Hepatotoxicity – yellow coloration of urine, jaundice, hepatitis
- • Pulmonary embolism, blood clots
- • Severe necrosis
- • Gastrointestinal perforation, bleeding
- • Fracture or risk of bone demineralization
Important Safety and Monitoring Information
- • To monitor regularly during the therapy
- • Total blood count
- • Hepatic functions
- • Kidney functions
- • Local tissue necrosis
- • Risks of bleeding
- • Thromboembolic events
Warning:
To be used under medical supervision, an oncologist specialist.
Storage
It should be stored at 2-8 degrees Celsius, protected from light.
Aprazer Healthcare: Global Leader in Advanced Oncology Solutions
Aprazer Healthcare, the leader in oncology care, manufactures the widest range of advanced care medicines and the latest innovative solutions.
WHO- GMP certified, assured therapeutic efficacy and quality.
Globally available in 50+ countries
FAQ
Frequently Asked Questions
Which is the affordable, globally available Fulvestrant injection?
Fulvekast prefilled syringe.
It offers precise and accurate dose delivery.
It is manufactured by Aprazer Healthcare.
How is Fulvekast (fulvestrant) injection administered?
It is given as an intramuscular injection in two separate doses.
- Loading dose
- Maintaining dose
What functions are monitored with Fulvekast (fulvestrant) injection?
- Liver functions
- Bleeding risk
- Blood functions
- pregnancy status
- Neurological changes
Can Fulvekast (fulvestrant) prefilled syringe be injected at home?
It should not be injected by an untrained person.
It needs deep insertion.
How to store Fulvekast (fulvestrant) injection?
Keep syringes at low temperature.
2-8 degrees Celsius.
Why avoid it in pregnancy?
It can harm the fetus.
Delay planning pregnancy
Avoid breastfeeding
Do not use birth control pills with Fulvekast (fulvestrant) injection?
It may reduce fulvestrant efficacy.
Aspirin cannot be used with Fulvekast (fulvestrant) injection. Why?
It increases the risk of bleeding.
Ecospirin dose is adjusted
Name the pharmaceutical manufacturer known for oncology drugs?
Aprazer healthcare is the oncology medicine manufacture.
